Ann & Robert Lurie Children's Hospital of Chicago

Chicago, Illinois 60614

1 studies enrolling now · 17 studies all time

What they study most

Acute Respiratory Distress Syndrome in Children, Beta-Thalassemia, Cardiac Arrest, Out-Of-Hospital, Cerebral Edema, Congenital Heart Disease in Children, Cystic Fibrosis, Diabetic Ketoacidosis, Genetic Diseases, Inborn, Graft-versus-Host Disease, Hematologic Diseases, Hematological Diseases, Hemoglobinopathies

Studies at this site

• Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) — Recruiting now
• PROSpect: Prone and Oscillation Pediatric Clinical Trial — Running, not enrolling
• STeroids to REduce Systemic Inflammation After Infant Heart Surgery — Completed
• Pediatric Urology Recovery After Surgery Endeavor (PURSUE) — Running, not enrolling
• A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia — Completed
• A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
• A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease — Completed
• Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA TC Combination Therapy in Participants With Cystic Fibrosis Who Are 6 Years of Age and Older — Completed
• Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del — Completed
• Acute Graft-versus-Host Disease Treatment (BMT CTN 0802) — Completed
• Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age — Completed
• Follow-up of the PEPITES Study to Evaluate Long-term Efficacy and Safety of Viaskin Peanut in Children — Status unconfirmed
• A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation — Completed
• A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) — Completed
• Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) — Completed
• Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age — Stopped early
• Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis — Completed